kidney stones and glp-1 Renal effects of receptor agonists tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Frontiers | GLP−1 receptor agonists

Published December 2, 2025

Body Composition Boost: Notably, the tea group experienced favorable changes in body fat percentage and lean mass compared to controls

Ozempic is approved for type 2 diabetes (0.25 mg to 2 mg), while Wegovy is approved for chronic weight management (up to 2.4 mg) and to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity Exenatide extended-release (Bydureon BCise) : Once-weekly injection using microsphere technology Liraglutide (Victoza, Saxenda) : Once-daily injection

Do you use food as reward or comfort